FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W376225> ?p ?o ?g. }

• W376225 abstract "As a general rule, the lowest-dose oral contraceptive should be prescribed that minimizes side effects while maintaining contraceptive protection. A woman who experiences mild side effects should be encouraged to tolerate symptoms for three menstrual cycles before a decision is made to change the prescription. Compliance may also be improved by informing women of the noncontraceptive health benefits of oral contraceptives: less menstrual blood loss and a lower incidence of menorrhagia, irregular bleeding, benign breast disease, endometrial cancer, dysmenorrhea, ovarian cysts or tumors, and salpingitis. Adequate patient education and supportive counseling are key factors in patient satisfaction and hence compliance.The effectiveness of monophasic and multiphasic oral contraceptives (OCs) depends on their ability to suppress ovulation, change endometrial growth and ovum receptivity, and reduce cervical mucus receptivity to sperm. They are all more than 99% effective, but, depending on the type and dose of hormone components, they have different side effects. The estrogen component (ethinyl estradiol) of most new OCs is between 30 and 35 mcg, which reduces the risk of estrogen side effects, especially thromboembolism and hypertension. The Food and Drug Administration does not recommend use of an OC with an estrogen component for lactating mothers, while the American College of Obstetrics and Gynecology and the American Academy of Pediatrics believe it is fine. Estrogen may protect against coronary artery disease, yet the estrogen component of today's OCs is so low that the progestin component may cancels this beneficial effect. It also prevents breakthrough bleeding. The most frequently used progestins in OCs are norethindrone and norgestrel. They prevent ovum implantation, sperm penetration through the cervical mucus, and ovulation. Progestins, especially norgestrel, increase the risk of coronary artery disease. Other side effects include acne and weight gain. Progestin benefits are reduced menstrual blood loss, pain during menstruation, premenstrual tension, and endometrial cancer risk. The ideal estrogen-progestin balance depends on the individual, but the estrogen component should be between 30 and 35 mcg, and the progestin component should be the lowest possible dose to reduce metabolic side effects. If an OC user with a well stabilized cycle who takes another recently prescribed drug experiences unexpected breakthrough bleeding or spotting, this change may indicate a drug interaction. Absolute and/or possible contraindications of OC use are smoking after age 35, history of breast or endometrial cancer, liver disease or impaired liver function, cardiovascular risk factors, and diabetes mellitus." @default.
• W376225 created "2016-06-24" @default.
• W376225 creator A5058498060 @default.
• W376225 date "1992-11-15" @default.
• W376225 modified "2023-10-16" @default.
• W376225 title "Benefits and risks of oral contraceptive use" @default.
• W376225 cites W1878925879 @default.
• W376225 cites W2054452226 @default.
• W376225 cites W2058037912 @default.
• W376225 cites W2060293830 @default.
• W376225 cites W2062694421 @default.
• W376225 cites W2084736550 @default.
• W376225 cites W2089638280 @default.
• W376225 cites W2109489157 @default.
• W376225 cites W2127282672 @default.
• W376225 cites W2336559915 @default.
• W376225 cites W2596242802 @default.
• W376225 cites W27472189 @default.
• W376225 cites W4240178516 @default.
• W376225 cites W4248925704 @default.
• W376225 cites W4255773516 @default.
• W376225 doi "https://doi.org/10.1080/00325481.1992.11701539" @default.
• W376225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1437913" @default.
• W376225 hasPublicationYear "1992" @default.
• W376225 type Work @default.
• W376225 sameAs 376225 @default.
• W376225 citedByCount "4" @default.
• W376225 countsByYear W3762252021 @default.
• W376225 crossrefType "journal-article" @default.
• W376225 hasAuthorship W376225A5058498060 @default.
• W376225 hasConcept C121608353 @default.
• W376225 hasConcept C126322002 @default.
• W376225 hasConcept C131872663 @default.
• W376225 hasConcept C2777088508 @default.
• W376225 hasConcept C2777164284 @default.
• W376225 hasConcept C2777689261 @default.
• W376225 hasConcept C2777702977 @default.
• W376225 hasConcept C2777902738 @default.
• W376225 hasConcept C2779076696 @default.
• W376225 hasConcept C2779742232 @default.
• W376225 hasConcept C2779771394 @default.
• W376225 hasConcept C2908647359 @default.
• W376225 hasConcept C29456083 @default.
• W376225 hasConcept C2986817661 @default.
• W376225 hasConcept C71315377 @default.
• W376225 hasConcept C71924100 @default.
• W376225 hasConcept C99454951 @default.
• W376225 hasConceptScore W376225C121608353 @default.
• W376225 hasConceptScore W376225C126322002 @default.
• W376225 hasConceptScore W376225C131872663 @default.
• W376225 hasConceptScore W376225C2777088508 @default.
• W376225 hasConceptScore W376225C2777164284 @default.
• W376225 hasConceptScore W376225C2777689261 @default.
• W376225 hasConceptScore W376225C2777702977 @default.
• W376225 hasConceptScore W376225C2777902738 @default.
• W376225 hasConceptScore W376225C2779076696 @default.
• W376225 hasConceptScore W376225C2779742232 @default.
• W376225 hasConceptScore W376225C2779771394 @default.
• W376225 hasConceptScore W376225C2908647359 @default.
• W376225 hasConceptScore W376225C29456083 @default.
• W376225 hasConceptScore W376225C2986817661 @default.
• W376225 hasConceptScore W376225C71315377 @default.
• W376225 hasConceptScore W376225C71924100 @default.
• W376225 hasConceptScore W376225C99454951 @default.
• W376225 hasLocation W3762251 @default.
• W376225 hasLocation W3762252 @default.
• W376225 hasOpenAccess W376225 @default.
• W376225 hasPrimaryLocation W3762251 @default.
• W376225 hasRelatedWork W1419805799 @default.
• W376225 hasRelatedWork W2016073860 @default.
• W376225 hasRelatedWork W2094416739 @default.
• W376225 hasRelatedWork W2273342730 @default.
• W376225 hasRelatedWork W2281829336 @default.
• W376225 hasRelatedWork W2296413723 @default.
• W376225 hasRelatedWork W2359861821 @default.
• W376225 hasRelatedWork W2270240426 @default.
• W376225 hasRelatedWork W2285637312 @default.
• W376225 hasRelatedWork W3024252950 @default.
• W376225 isParatext "false" @default.
• W376225 isRetracted "false" @default.
• W376225 magId "376225" @default.
• W376225 workType "article" @default.